COMP <GO>
XYL vs UNP // EV/EBITDA & P/E VALUATION
Xylem Inc. Common Stock New (NYSE) VS. Union Pacific Corporation (NYSE) • 15-METRIC TALLY: XYL 7
— UNP 8
▲ EV/EBITDA & P/E VALUATION LEADER: XYL
LAST: $92.40 (+1.81%) • MKT CAP: $20.81B
valuation
13.2x
LAST: $304.00 (+0.69%) • MKT CAP: $179.42B
valuation
15.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XYL VS. UNP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XYL | UNP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 38.50% | 41.00% | -2.50 | UNP | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.50% | 20.10% | -11.60 | UNP | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 13.2x | 15.3x | -2.10 | XYL | /valuation <GO> |
| Free Cash Flow Yield | 4.01% | 3.06% | +0.95 | XYL | /fcf-yield <GO> |
| Operating Margin | 13.50% | 40.20% | -26.70 | UNP | /operating-margins <GO> |
| Net Profit Margin | 10.60% | 29.10% | -18.50 | UNP | /net-margins <GO> |
| Revenue Growth (YoY) | 5.50% | 1.10% | +4.40 | XYL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.88% | 1.80% | +0.08 | XYL | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.28 | 4.31 | -1.03 | UNP | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 6/9 | +3.00 | XYL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 7.00% | -0.40 | XYL | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 33.5 | 70.0 | -36.54 | UNP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 1.03 | -0.12 | UNP | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.2x | 23.3x | -3.10 | XYL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $20.81B | $179.42B | -$158.61B | UNP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XYL REV | UNP REV | XYL GROSS % | UNP GROSS % | XYL FCF | UNP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.04B | $24.51B | 38.5% | 44.0% | $834.4M | $5.50B |
| FY 2024 | $8.56B | $24.25B | 37.5% | 44.0% | $877.7M | $5.89B |
| FY 2023 | $7.36B | $24.12B | 44.0% | 44.0% | $505.6M | $7.29B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XYL // BETA 0.91
UNP // BETA 1.03